Literature DB >> 16944027

Combined gemcitabine and alpha-interferon therapy for pancreatic cancer: report of a case.

Hirozumi Sawai1, Yuji Okada, Moritsugu Tanaka, Hitoshi Funahashi, Minoru Yamamoto, Hiromitsu Takeyama, Tadao Manabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16944027     DOI： 10.1007/s10620-006-8050-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  18 in total

1.  Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.

Authors:  Y Nukui; V J Picozzi; L W Traverso
Journal:  Am J Surg       Date:  2000-05       Impact factor: 2.565

2.  A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

Authors:  S Cascinu; G Gasparini; V Catalano; R R Silva; G Pancera; A Morabito; P Giordani; D Gattuso; G Catalano
Journal:  Ann Oncol       Date:  1999-11       Impact factor: 32.976

Review 3.  Pancreatic carcinoma.

Authors:  A L Warshaw; C Fernández-del Castillo
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

4.  Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity.

Authors:  N Kemeny; A Younes; K Seiter; D Kelsen; P Sammarco; L Adams; S Derby; P Murray; C Houston
Journal:  Cancer       Date:  1990-12-15       Impact factor: 6.860

5.  A new method of intra-arterial regional chemotherapy with more selective drug delivery for locally advanced pancreatic cancer.

Authors:  H Ohigashi; O Ishikawa; S Imaoka; Y Sasaki; T Kabuto; M Kameyama; H Furukawa; M Hiratuka; S Nakamori; H Nakano; T Yasuda; T Iwanaga
Journal:  Hepatogastroenterology       Date:  1996 Mar-Apr

Review 6.  Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.

Authors:  S Wadler; E L Schwartz
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

7.  A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma.

Authors:  H Ulrich-Pur; G V Kornek; M Raderer; K Haider; W Kwasny; D Depisch; R Greul; B Schneeweiss; G Krauss; J Funovics; W Scheithauer
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

Review 8.  Recent discoveries in cancer genetics of exocrine pancreatic neoplasia.

Authors:  S A Hahn; W H Schmiegel
Journal:  Digestion       Date:  1998-08       Impact factor: 3.216

9.  Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.

Authors:  A Theodors; R M Bukowski; J S Hewlett; R B Livingston; J K Weick
Journal:  Am J Clin Oncol       Date:  1982-10       Impact factor: 2.339

10.  Enhancement of integrins by interleukin-1alpha, and their relationship with metastatic and invasive behavior of human pancreatic ductal adenocarcinoma cells.

Authors:  Hirozumi Sawai; Hiromitsu Takeyama; Minoru Yamamoto; Akiyoshi Furuta; Hitoshi Funahashi; Yuji Okada; Mikinori Sato; Moritsugu Tanaka; Tadao Manabe
Journal:  J Surg Oncol       Date:  2003-01       Impact factor: 3.454
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.